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บทคดัยอ่ 
วตัถปุระสงค์: เพื่อพฒันาสูตรต ารบัเบื้องต้นของยาชา ลโิดเคน (lidocaine)  
และพรโิลเคน (prilocaine) ในรปูแบบเจล และประเมนิคุณสมบตัเิชงิความรอ้นและ
พฤตกิรรมการไหล วิธีการศึกษา: ศึกษาคุณสมบตัเิชิงความรอ้นของสารดว้ย
เครื่องดฟิเฟอเรนเชียลสแกนนิงแคลอรมิเิตอร์ การละลายของยาในระบบตวัท า
ละลายรว่ม หาสารก่อเจลทีเ่หมาะสม และศกึษาพฤตกิรรมการไหลของต ารบั ผล
การศึกษา: ผลคุณสมบตัเิชงิความรอ้นของสารพบวา่ การผสมยาลโิดเคนตอ่พรโิล
เคนทีอ่ตัราส่วน 1:1 ท าใหเ้กดิระบบสารผสมยูเทกตกิขึ้นได ้ระบบตวัท าละลาย
รว่มทีเ่หมาะสมในการละลายยาทัง้สองชนิดคอืสารละลายแอลกอฮอล์ในน ้าความ
เขม้ขน้รอ้ยละ 35 โดยน ้าหนกั สารก่อเจลในต ารบัทีเ่หมาะสมคอืคาร์โบพอล 940 
(carbopol 940) เมื่อเทยีบกบัครมียาชาที่มขีายในทอ้งตลาด (EMLA® cream) 
พบวา่เจลทีพ่ฒันาขึน้มกีารไหลทีค่ลา้ยคลงึกนัเป็นแบบซูโดพลาสตกิคอืยิง่ใหแ้รง
ยิง่ไหลง่าย และพบว่าการเปลี่ยนแปลงอุณหภูมขิณะท าการทดสอบไม่มผีลต่อ
รูปแบบการไหลของต ารบั สรปุ: การพฒันาสูตรต ารบัและการประเมนิเจลยาชา 
ลโิดเคนและพรโิลเคนในเบื้องตน้นี้  สามารถน าไปพฒันาต่อยอดให้เกดิเป็นสูตร
ต ารบัทีเ่หมาะสมตอ่ไปไดใ้นอนาคต  
ค าส าคญั: ลโิดเคน, พรโิลเคน, เจล, สารผสมยูเทกตกิ, คุณสมบตัเิชงิความรอ้น, 
พฤตกิรรมการไหล  
Abstract 
Objectives: To develop a gel containing lidocaine and prilocaine and to 
characterize its thermal and rheological properties. Methods: The thermal 
property by differential scanning calorimeter (DSC), solubility of the drugs in 
co-solvent system, suitable gelling agent and rheological behavior were 
evaluated. Results: DSC study revealed that lidocaine:prilocaine at the 
ratio of 1:1 could form a eutectic mixture. The co-solvent system, 35% w/w 
ethanol was used to dissolve these drugs. The 1% w/w carbopol 940 was 
an appropriate gelling agent. The developed gel and EMLA® cream showed 
a comparable pseudoplastic flow (shear thinning system). In addition, the 
changing of temperature did not affect the gels’ rheological behavior. 
Conclusion: This study of the lidocaine-prilocaine gel formulation can be 
useful for the further development.  
Keyword: lidocaine, prilocaine, gel, eutectic mixture, thermal properties, 
rheological behaviors 
 
Introduction 
Periodontitis is the inflammation and infection of the 
ligaments and bones that support the teeth. Loss of support 
causes the teeth to become loose and eventually fall out.1 
The treatment of advanced periodontitis may require dental 
surgery that local anesthetics may be needed. Local 
anesthetics commonly used in dentistry include lidocaine, 
mepivacaine, prolocaine, and prilocaine. Lidocaine or 
lignocaine is amide type local anesthetics with a fast onset 
of action, medium duration of action, and low toxicity. 
Because of its good properties, lidocaine is also widely used 
to relieve skin pain caused by skin irritation such as sun 
burn, insect bite, climber or tree poisoning, small injury, 
bruise/scratch, and hemorrhoids and pain in oral cavity. In 
addition, lidociane is used as an anesthetic to the gum in 
dental procedures and the skin in surgical procedures. 
Prilocaine is amide type local anesthetics which has 
pharmacokinetic and pharmacodynamic profile similar to 
lidocaine. The onset of action of prilocaine is fast; however 
the duration of action is longer than lidocaine. Another 
advantage of prilocaine over lidocaine is its lower toxicity 
with a faster excretion and a higher volume of distribution. 
The combination of lidocaine and prilocaine provides a good 
local anesthetic effect with low toxicity.2-4 The mean onset 
time of surgical analgesia of both lidocaine and prilocaine is 
10 min.5 Lidocaine is eliminated with a terminal elimination 
phase half-life (t ½ ) of 2.9 hrs. The total body clearance of 
lidocaine is 68 L/h. While prilocaine is rapidly eliminated with 
a t ½  of 2.1 hrs which is somewhat comparable to that of 
lidocaine; the total body clearance of prilocaine (150 L/h) 
was higher than that of lidocaine. Both compounds 
demonstrate a comparable volume of distribution (Vd); while 
both the volume of distribution at steady-state (Vss) and the 
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volume of distribution in the second compartment (Vβ) 
values of prilocaine are 1.6 times higher than those of 
lidocaine.5 
Both lidocaine and prilocaine separately are solid bases. 
However, when they are mixed together, the eutectic mixture 
is formed from solid to oil without the use of any solvent. 
The melting point of lidocaine-prilocaine eutectic mixture is 
lower than those of the individual components and in liquid 
form. Therefore, the mixture was definitely homogeneously 
incorporated into the gel base.6,7  
This study aimed to develop the local anesthetics gel 
containing lidocaine and prilocaine, and to characterize the 
thermal and rheological properties of the prepared gel. The 
thermal property of the drugs, gelling agent and mixtures 
were determined. The solubility of the drug and eutectic 
mixture were evaluated. The suitable kind of gelling agent 
and the rheological behavior of developed gels were 
examined. 
 
Materials and Methods 
 
Materials 
Lidocaine, prilocaine and EMLA® cream (AstraZeneca 
Canada Inc., Ontario, Canada) were kindly supported from 
T. Man Pharma Limited Partnership. Poloxamer 407, 
carbopol 940, carbopol ultralize, hydroxyethyl cellulose 
(HEC) and hydroxypropyl methylcellulose (HPMC) were 
purchased from VITA Co., Ltd, Bangkok, Thailand. 
Polyethylene oxide (polyox 303) (Lot. No. GA263364, 
Colorcon Asia Pacific Pte., Ltd, Singapore), polyox N12K 
(Lot. No. GA229281, Colorcon Asia Pacific Pte., Ltd, 
Singapore), sepigel 305 (B/No. T52135, Adinop Co., Ltd.), 
sepiplus 265 (B/No. T44031, Adinop Co., Ltd.), sepiplus 400 
(B/No. T43131), simulgel EG (B/No. T51411) and simulgel 
NS (B/No. T40641) were purchased from Adinop Co., Ltd., 
Bangkok, Thailand. Ethanol, N-methyl pyrrolidone, 
triethanolamine, propylene glycol and hydrochloric were 
purchased from PC drug, Bangkok, Thailand.  
 
Methods 
Thermal analysis 
The differential scanning calorimeter (DSC) (Pyris 
Sapphrie DSC, Standard 115V, Perkin Elmer instruments, 
Japan) was used to investigate the melting temperature of 
prilocaine, lidocaine, carbopol 940 and poloxamer 407 and 
thermal behavior of the mixture of lidocaine:prilocaine at the 
ratios of 1:1, 1:9 and 9:1, lidocaine:carbopol 940 at the ratio 
of 1:1, prilocaine:carbopol 940 at the ratio of 1:1 and 
lidocaine:prilocaine:carbopol 940 at the ratio of 1:1:2, 
lidocaine:poloxamer 407 at the ratio of 1:1, 
prilocaine:poloxamer 407 at the ratio of 1:1 and  
lidocaine:prilocaine:poloxamer 407 at the ratio of 1:1:2. The 
DSC was operated under N2 atmosphere and heated from 
10 to 200 °C at a heating rate of 10 °C/min.  
 
Solubility study of prilocaine and lidocaine  
Lidocaine:prilocaine at a ratio of 1:1 for 5% w/w was 
used for solubility study. The co-solvent systems of ethanol-
water and NMP-water at 2, 4, 6, 8, 10, 15, 20, 30, 35 and 
50% w/w of ethanol and NMP were used. The drugs were 
mixed into each co-solvent system and the clarity of those 
solutions was investigated.   
 
The selection of suitable gelling agent  
Gels were prepared by various gelling agents such as 
poloxamer 407, carbopol 940, carbopol ultralize, HEC, 
HPMC, polyox 303, polyox N12K, sepigel 305, sepiplus 265, 
sepiplus 400, simulgel EG and simulgel NS. These gelling 
agents at various concentrations were dispersed into water 
to form gel bases. The viscosity and clarity of gels were 
investigated. The pH of suitable gel bases was adjusted by 
concentrated HCl and triethanolamine to pH 9 to allow for 
the penetration of the local anesthetic agents.8  
 
Preparation of lidocaine and prilocaine gel  
2.5% w/w lidocaine and 2.5% w/w prilocaine were 
prepared by dissolving the two compounds in 35% w/w 
ethanol. 1% w/w of carbopol 940 and 15% w/w of propylene 
glycol, as gelling agents, were prepared by dissolving the 
two substances in purified water. These two systems were 
further mixed together and the pH was adjusted to 9 with 
triethanolamine.  
 
Rheological behavior study 
The rheological behavior of gels containing lidocaine and 
prilocaine was investigated and compared with that of 
EMLA® cream by determining their shear stress as a 
function of shear rate in a Brookfield DV-III Ultra 
programmable rheometer (HADV-III U CP, Brookfield 
Engineering Laboratory, USA). The effect of temperature on 
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rheological behavior of gels was tested. The measurements 
were conducted at three different temperatures, specifically 
4, 28 and 35 °C.  
 
Results and Discussions  
 
Thermal properties 
DSC is a method to determine the melting temperature 
and incompatibility of substances. DSC thermograms in 
Figure 1 show the melting points of pure lidocaine (1a), pure 
prilocaine (1b) and pure poloxamer 407 (1d) with the 
endothermic peaks at 66.5, 37.9 and 53.1 °C, respectively. 
However, the carbopol 940 showed a broad endothermic 
peak of dehydration at 61.7 °C (Figure 1c).  
 
 
 
 Figure 1  DSC thermograms of a) lidocaine, b) prilocaine, 
c) carbopol 940 and d) poloxamer 407.   
 
DSC thermogram of lidocaine:prilocaine at the ratio of 
1:1 showed the eutectic behavior that the mixture became a 
liquid form at room temperature and the melting point was 
lower than that of pure drugs (Figure 2a). The eutectic 
mixture system could promote the solubility and absorption 
of the drugs.9 Similarly,1:1 eutectic mixture of lidocaine and 
prilocaine emulsified in water was investigated with a poly 
(dimethylsiloxane) membrane partition model.10 The major 
advantages of using the emulsion formulation based on a 
eutectic mixture include the presence of local anesthetic 
bases in their permeable uncharged forms and the use of a 
low water content system (poor water) as the vehicle which 
could provide a saturated system at low concentrations. The 
droplets consist of a dissolvable drug and act as reservoirs 
to obtain steady-state release and the fluid state of the 
excess drug provides a dissolution rate higher than that from 
a solid state.10 On the other hand, Chun et al. found that the 
eutectic mixture could be formed with the ratio of 3:1 
(lidocaine:prilocaine) by DSC study. The permeation of both 
lidocaine and prilocaine increased; however crystallization 
was observed.11 The melting points of lidocaine:prilocaine 
mixtures at the ratios of 1:9 and 9:1 revealed the 
endothermic peaks at 33.2 °C of prilocaine (Figure 2b) and 
58.4 °C of lidocaine (Figure 2c), respectively.  
 
 
 
 Figure 2  DSC thermogram of lidocaine:prilocaine at the 
ratio of a) 1:1 b) 1:9  and c) 9:1.  
 
However, the eutectic mixture did not occur with these 
ratios. The DSC thermogram of 1:1 lidocaine:carbopol 940 
only exhibited the melting point of lidocaine (Figure 3a) and 
that of 1:1 prilocaine:carbopol 940 only exhibited the melting 
point of prilocaine (Figure 3b). DSC thermogram of 1:1:2 
lidocaine:prilocaine:carbopol 940, with carbopol mixed with 
each drug before mixing altogether, showed individual 
melting points of both prilocaine and lidocaine (Figure 3c). 
These result indicated that the components in the mixture 
were intact because the melting point of each substance was 
not changed.12 Since lidocaine and prilocaine were 
separately enwrapped by carbopol 940 polymer before the 
final mixing, the contact of the two anesthetic agents was 
thus prevented. The eutectic formation was therefore 
disturbed by carbopol 940. On the other hand, with lidocaine 
and prilocaine mixed together before the final mixing with 
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carbopol 940, DSC thermograms of 1:1:2 lidocaine: 
prilocaine:carbopol 940 exhibited only the melting point of 
the eutectic mixture (Figure 3d). This result indicated that the 
eutectic behavior was detectable.  
  
 
 Figure 3  DSC thermograms of a) 1:1 lidocaine:carbopol 
940, b) 1:1 prilocaine:carbopol 940, c) 1:1:2  lidocaine: 
prilocaine: carbopol 940 when carbopol was mixed with the 
single pure drug before mixing the other drug and d) 1:1:2  
lidocaine:prilocaine:carbopol 940 when both of pure drugs were 
mixed before mixing with carbopol.  
 
DSC thermograms of 1:1 lidocaine:poloxamer 407 and 
1:1 prilocaine:poloxamer 407 exhibited two distinct melting 
points of the two anesthetic agents (Figures 4a and 4b, 
respectively). As expected, DSC thermograms of 1:1:2 
lidocaine:prilocaine:poloxamer 407, with both drugs mixed 
before the final mixing with poloxamer, showed only the 
melting point of the eutectic mixture (Figure 4c). This finding 
could also be explained as previously mentioned that mixing 
individual anesthetic agents with the polymer before the final 
mixing could prevent the formation of eutectic mixture. The 
contact of the two drugs in their solid state induced the 
melting point depression and mutually dissolve with each 
other in the liquid state because of an entropy-driven 
phenomenon.13 The intimate contact and mutual solubility 
between eutectic-forming materials are the necessary and 
sufficient criteria for eutectic formation.14 
 
 Figure 4  DSC thermograms of a) 1:1 lidocaine:poloxamer 
407, b) 1:1 prilocaine:poloxamer 407 and c) 1:1:2 lidocaine: 
prilocaine:poloxamer 407.  
 
Solubility of prilocaine and lidocaine 
Lidocaine and prilocaine at a ratio of 1:1 could form a 
eutectic mixture when they were mixed together at room 
temperature. The oily liquid of eutectic mixture mixed easily 
with the gel although it was immiscible to water. Therefore, 
the solubility of the drug and the mixture was tested. Both 
drugs were soluble in ethanol and NMP, but were insoluble 
in water.15 The co-solvent system was applied to dissolve 
the drugs. The results showed that each of the two drugs 
was separated from NMP-water phase at all NMP 
concentrations (2, 4, 6, 8, 10, 15, 20, 30, 35 and 50% w/w). 
On the other hand, the drugs could be dissolved in ethanol-
water system. The clarity of solutions increased when the 
amount of ethanol increased, and became a clear solution 
when 35% w/w ethanol was used.  
 
The suitable gelling agent 
Most of all, 1% w/w carbopol 940 was the suitable gelling 
agent for the local anesthetic gel. In accordance with other 
research, the carbopol gel displayed a clear homogeneous 
texture16,17 and exhibited a proper viscosity at pH 9. The 
clarity, viscosity and pH of 1% w/w carbopol 940 increased 
when triethanolamine was added. However, the viscosity of 
that gel slightly decreased when the system pH was 
adjusted to 9. All local anesthetics are bases and their pKa 
values are greater than 7.4, the physiologic pH.18 Therefore, 
at pH 9, a greater proportion of the molecules exist in the 
free base forms which are lipophilic and able to penetrate 
the stratum corneum.19  
 
Rheological behavior  
Rheological behavior of lidocaine-prilocaine gel (Figure 
5) was compared with that of EMLA® cream (Figure 6)  
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 Figure 5  Rheological behavior of lidocaine-prilocaine gel at a) 4 °C, b) 28 °C and c) 35 °C.  
 
 
 
 
 
 
 
 
 
 
 
 Figure 6  Rheological behavior of EMLA® cream at a) 4 °C, b) 28 °C and c) 35 °C.  
 
 
All preparations showed comparable rheological behaviors. 
The shear rate was increased with the increasing shear 
stress; however, such association was in a nonlinear 
fashion. This non-linear relationship was considered a 
pseudoplastic flow, or shear thinning system, which was 
usually found in the system using both natural and synthetic 
polymers.20-22 In accordance with previous research, these 
results indicated that the changing of temperature did not 
affect the rheological behavior of the gel formulation.1 
 
Conclusion 
 
The DSC thermogram of lidocaine:prilocaine at the ratio 
of 1:1 showed the eutectic behavior that could promote the 
solubility and absorption of the drugs. With the formula of 
lidocaine:prilocaine:carbopol 940 at the ratio of 1:1:2, 
carbopol was separately mixed with the single drugs before 
the final mixing. DSC thermograms showed that the melting 
point of each substance did not change. This indicated that 
each component in the mixture was compatible. However, 
the eutectic mixture could not be formed. On the other hand, 
the eutectic mixture occurred when lidocaine was mixed with 
prilocaine before the final mixing with the polymer. The 
intimate contact of the two drugs was necessary for eutectic 
formation. Carbopol 940 was the suitable gelling agent for 
the gel formulation. For rheological behavior, the gel 
containing lidocaine and prilocaine exhibited the 
pseudoplastic flow (shear thinning system). The changing of 
temperature did not affect the rheological behavior of the 
developed lidocaine-prilocaine gel. These results were useful 
for further development of the lidocaine-prilocaine gel 
formulation. 
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